LGG-34. Nephrological impact of BRAF inhibitors in a pediatric population of central nervous system tumors: a single institution experience

BRAF inhibitors (iBRAF) are under investigations in ongoing clinical trials for pediatric brain tumor treatment. Preliminary data regarding the pediatric population report pyrexia, hematological, dermatological, cardiac, and ophthalmic toxicities among the most common adverse events. Acute kidney in...

Descripción completa

Detalles Bibliográficos
Autores principales: Verrico, Antonio, Crocco, Marco, La Porta, Edoardo, Angeletti, Andrea, Verrina, Enrico, Iurilli, Valentina, Piatelli, Gianluca, Piccolo, Gianluca, Milanaccio, Claudia, Garrè, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Low Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164843/
http://dx.doi.org/10.1093/neuonc/noac079.346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164843/
http://dx.doi.org/10.1093/neuonc/noac079.346

Ejemplares similares